Security key
09061G101
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q1 2019 13F Holders as of 31 Mar 2019
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 178,407,022
- Total 13F value
- $15,847,079,543
- Share change
- -900,195
- Put/Call ratio
- 147%
- SEC-reported price per share
- $88.83
- Number of holders
- 475
- Value change
- -$79,141,968
- Number of buys
- 248
- Number of sells
- 186
- Shares outstanding
- 192,632,743
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2019
Institutions
475
Top holders
10
BMRN full security history
Ownership snapshot
Full 13F holder table
BIOMARIN PHARMACEUTICAL INC SEC filings
BIOMARIN PHARMACEUTICAL INC company facts
Broader feeds
Ownership snapshot
Top reported holders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
15/15
Latest evidence
31 Dec 2018
13F
Lead comparable stake: 9.5%
Showing 1-6 of 15 holder rows.
Quick read
Capital Research Global Investors leads the comparable SEC ownership view at 9.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital Research Global Investors's linked filing trail.
Comparable ownership
Top 5
Capital Research Global Investors
9.5%
VANGUARD GROUP INC
8.1%
PRIMECAP MANAGEMENT CO/CA/
7.4%
BlackRock Finance, Inc.
7%
JENNISON ASSOCIATES LLC
6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
Company
|
9.5%
|
$1,558,599,000
18,304,163 shares
|
— | 31 Dec 2018 |
| VANGUARD GROUP INC |
13F
Company
|
8.1%
|
$1,323,393,000
15,541,904 shares
|
— | 31 Dec 2018 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
7.4%
|
$1,207,867,000
14,185,173 shares
|
— | 31 Dec 2018 |
| BlackRock Finance, Inc. |
13F
Company
|
7%
|
$1,156,215,000
13,578,562 shares
|
— | 31 Dec 2018 |
| JENNISON ASSOCIATES LLC |
13F
Company
|
6%
|
$987,779,000
11,600,460 shares
|
— | 31 Dec 2018 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
3.9%
|
$646,228,000
7,589,294 shares
|
— | 31 Dec 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
475
Shares
178,407,022
Rows available
475
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2019 vs Q1 2019 Across Filers
Q1 2019 holders
475
Q1 2019 holders
475
Holder diff
0
| Investor | Q1 2019 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q1 2019 value | Q1 2019 value | Value change | Value Chg % |
|---|